Skip to main content
. 2021 Dec 21;12:757120. doi: 10.3389/fphar.2021.757120

FIGURE 2.

FIGURE 2

Mechanism of action of CDK4/6 inhibitors in CRC cells. Palbociclib, Ademaciclib, Ribociclib, CINK4 and Trilaciclib are able to prevent the formation of Cyclin D/CDK4/6 complexes, which reduces Retinoblastoma phosphorylation and induces G1 cell cycle arrest. Palbociclib has been shown to be effective in promoting p53 transcription after irradiation as well.